WHO antibacterial preclinical pipeline

WHO’s first global review of antibacterial products in preclinical development captures 252 antibacterial products that are being developed in 145 institutions around the world. Candidate products are reported by country of development, preclinical stage, treatment modality, infection stage being targeted, product type, mode of action, and pathogen category for pathogen-specific products. Details of bacterial spectrum target, route of administration and developers are also reported.